arrow
G

Giustino Parruti

g d'annunzio university of chieti-pescara
H指数:39
被引数:5,876

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections
2025-02-240
OAAI
Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections

达巴万辛在现实生活中的安全性和有效性: 对治疗皮肤/软组织和其他难以治疗的感染的大型单中心病例系列的回顾性分析

2024-11-080
OA
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21
2024-07-192
OAAI
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use

腹腔内感染的管理: 意大利抗菌药物使用优化委员会的建议

2024-06-082
OAAI
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia
2024-03-110
OAAI
Prevalence and Characterization of Resistance Profiles of Unusual HCV Subtypes in Italy within the Italian Resistance Network Vironet C
2024-02-010
PRE
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study

在意大利Omicron时代,使用莫尔尼吡拉韦或尼马吡韦加利托那韦治疗的有临床进展风险的SARS-CoV-2感染患者死亡率的现实比较: 一项全国性的队列研究

2023-08-019
OAAI
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
2023-06-087
OAAI
Severe Streptococcus equi Subspecies zooepidemicus Outbreak from Unpasteurized Dairy Product Consumption, Italy
2023-05-017
OAAI
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study
2023-03-108
OAAI
Reversibility of Central Nervous System Adverse Events in Course of Art
2022-05-1110
OAAI
THE UTILITY OF EARLY HIGH FLOW NASAL OXYGEN THERAPY (FROM ER TO DISCHARGE AND HOME) IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
CHEST
IF8.6
2021-10-010
OAAI